Trademark: 90154217
Status Date
Monday, May 8, 2023
Filing Date
Wednesday, September 2, 2020
Published for Opposition
Tuesday, February 9, 2021
Abandoned Date
Monday, May 8, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
May 8, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 8, 2023
Abandonment - No Use Statement Filed
Oct 17, 2022
Teas Change Of Correspondence Received
Oct 17, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 17, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 12, 2022
Sou Extension 3 Granted
Sep 12, 2022
Sou Extension 3 Filed
Sep 12, 2022
Teas Extension Received
Mar 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2022
Sou Extension 2 Granted
Mar 28, 2022
Sou Extension 2 Filed
Mar 28, 2022
Teas Extension Received
Sep 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 27, 2021
Sou Extension 1 Granted
Sep 27, 2021
Sou Extension 1 Filed
Sep 27, 2021
Teas Extension Received
Apr 6, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 9, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2021
Published For Opposition
Jan 20, 2021
Notification Of Notice Of Publication E-Mailed
Jan 7, 2021
Approved For Pub - Principal Register
Jan 7, 2021
Assigned To Examiner
Oct 7, 2020
New Application Office Supplied Data Entered
Sep 5, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
